Farid Badria | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Kazutomo Sawai | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Kazutomo Sawai | Health Professions | Best Researcher Award

President from Hanshin Medical Co-op Daisan Clinic, Japan

Dr. Kazutomo Sawai is a distinguished Japanese physician-researcher specializing in nephrology and Kampo (traditional Japanese) medicine. He has made outstanding contributions to the understanding of glomerular regeneration, diabetic nephropathy, and molecular markers of kidney disease. With over two decades of clinical and research experience, Dr. Sawai combines modern medical science with traditional therapeutic approaches to address complex renal pathologies. His professional journey encompasses high-level academic training, fellowships at prominent institutions, and leadership roles within clinical practice and education. Since 2010, he has served as President of Daisan Clinic in Amagasaki, Hyogo, Japan, where he also champions patient education and community healthcare. Dr. Sawai’s international presence is marked by presentations at global nephrology congresses, highlighting his pivotal research on Connexin43 and Cyr61 expression in diabetic nephropathy and glomerulonephritis. His clinical insights are further enriched through his integration of Kampo medicine, reflected in his successful management of chronic cases through traditional prescriptions. A fellow of multiple Japanese medical societies, he has received notable honors for his scientific achievements. Dr. Sawai remains a committed clinician, educator, and researcher, dedicated to translational nephrology, patient-centered care, and the advancement of integrative medicine practices.

Professional Profile

Education

Dr. Kazutomo Sawai pursued his foundational medical education at the esteemed Kyoto University School of Medicine, obtaining his M.D. in 1995. Demonstrating an early interest in renal pathophysiology, he continued his academic journey by earning a Ph.D. in Renal Physiology from Kyoto University Graduate School of Medicine in 2004. His doctoral work focused on glomerular disease mechanisms and the role of angiogenic and podocyte-specific factors in kidney regeneration. Dr. Sawai’s postgraduate training included a comprehensive residency in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital between 1995 and 1997. He later undertook specialized fellowships in nephrology and dialysis therapy from 1998 to 2001 at both Saiseikai Nakatsu and Kyoto University Hospitals. Expanding his scope beyond conventional medicine, Dr. Sawai completed dual fellowships in Kampo medicine between 2015 and 2018 at Midorinokaze Clinic and Rakuwakai Otowa Hospital. This diverse academic and clinical training underpins his multidisciplinary approach to kidney care, integrating Western biomedical science with traditional Japanese therapeutics. Dr. Sawai’s strong academic background has laid a robust foundation for his research contributions and clinical leadership, positioning him as a key figure in the evolution of nephrology and holistic patient care in Japan.

Professional Experience

Dr. Sawai has cultivated an illustrious professional career marked by significant academic, clinical, and administrative roles. His early medical career began with residencies in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital from 1995 to 1997. He then specialized in nephrology and dialysis therapy during fellowships at these institutions through 2001. Dr. Sawai’s academic appointments include a role as Project Researcher in Internal Medicine at Kyoto University in 2004 and a notable tenure as Chief Researcher at the National Cardiovascular Center Research Institute in Osaka from 2004 to 2010. In 2010, he assumed the presidency of Daisan Clinic in Amagasaki, where he continues to practice, lead, and mentor. His responsibilities extend to community health, serving as Medical Director and Adviser for local home care services, and contributing as a committee member overseeing free and low-cost medical programs. He has also taught at Saiseikai Nakatsu Nursing School and Hanshin Cooperative Association Community College. With an integrated focus on internal medicine, nephrology, dialysis, and Kampo medicine, Dr. Sawai’s professional journey reflects a commitment to advancing holistic healthcare, clinical education, and community outreach.

Research Interest

Dr. Sawai’s research interests span the molecular, cellular, and clinical dimensions of nephrology. His work is particularly focused on the pathophysiology of glomerular diseases, including diabetic nephropathy, anti-GBM nephritis, and glomerulonephritis. He has extensively investigated the roles of podocyte-specific genes, such as Cyr61 (CCN1) and Connexin43, in renal injury and regeneration. These studies have led to insights into the mechanisms of podocyte dysfunction and the potential use of angiogenic and regenerative factors in predicting or improving renal outcomes. A pioneer in integrating traditional medicine into modern nephrology, Dr. Sawai has also explored the therapeutic applications of Kampo prescriptions in managing chronic symptoms such as dementia, hypertension, and neuropathic pain. His case studies highlight the efficacy of herbal formulations in complex clinical scenarios that often resist conventional treatment. His broader interest encompasses translational nephrology, where laboratory discoveries can inform clinical practice. With a comprehensive understanding of both biomedical science and traditional Japanese healing systems, Dr. Sawai’s research bridges disciplines to deliver patient-centered, evidence-based, and integrative kidney care. His continuous presence at national and international conferences further demonstrates his commitment to advancing nephrology and promoting the fusion of traditional and modern medical systems.

Research Skills

Dr. Sawai brings a sophisticated portfolio of research skills to the field of nephrology and integrative medicine. Trained in both clinical and bench research environments, he has demonstrated strong capabilities in experimental nephrology, molecular biology, and pathophysiological analysis. His core competencies include immunohistochemistry, gene expression profiling, and biomarker discovery, particularly focusing on proteins like Cyr61 and Connexin43 in renal pathology. His collaborative research has leveraged rodent models of glomerulonephritis and diabetic nephropathy to explore regeneration pathways in the kidney. Dr. Sawai’s ability to translate these findings into clinical insights distinguishes his work in translational medicine. Additionally, his skills extend to clinical trial design, retrospective case analysis, and Kampo prescription efficacy assessment, making him a rare blend of experimental and clinical researcher. He is also an experienced academic presenter and has delivered over 30 presentations at regional, national, and international conferences. His capacity for multidisciplinary collaboration, particularly in combining conventional nephrology with traditional Japanese Kampo medicine, reflects advanced integrative research skills. Through his leadership at Daisan Clinic, he continues to apply these skills in real-world settings, facilitating a seamless interface between research innovation and patient care.

Awards and Honors

Throughout his career, Dr. Kazutomo Sawai has received multiple accolades in recognition of his academic and research excellence. Among the earliest distinctions was the Miyake Memorial Award from Kyoto University Graduate School of Medicine in 2003, acknowledging his contributions to internal medicine and clinical science. In 2004, he was the recipient of the Tsujisaka Memorial Scholarship, awarded for scholarly promise and research potential in the field of renal physiology. The Young Researcher’s Award conferred at the 42nd Annual Meeting of the Japanese Society of Molecular Medicine in 2005 further highlighted his innovative work on glomerular regeneration. He also earned a Travel Grant from the American Society of Nephrology, which enabled him to present his research at international platforms and expand cross-border academic exchange. These honors not only affirm his impactful scientific work but also emphasize his contributions to the global discourse on nephrology. Dr. Sawai’s recognition by both Japanese and international institutions reflects the high quality and significance of his research. His continued academic output and interdisciplinary approach ensure that he remains at the forefront of innovation in renal medicine and integrative therapies.

Conclusion

Dr. Kazutomo Sawai stands out as a clinician-researcher of exceptional caliber, whose multifaceted career bridges the realms of nephrology, internal medicine, and Kampo therapeutics. His academic foundation at Kyoto University, combined with specialized fellowships in nephrology and traditional medicine, has shaped a unique professional identity that is both modern and rooted in tradition. As President of Daisan Clinic, he has made significant contributions to clinical nephrology while also enhancing community health services and medical education. Dr. Sawai’s research has had a profound impact on the understanding of podocyte biology, glomerular regeneration, and diabetic nephropathy, with practical applications for improving patient outcomes. His pioneering integration of Kampo medicine into nephrology offers novel approaches to managing chronic, treatment-resistant conditions. Despite a lack of editorial roles, his active participation in national and international scientific forums and multiple honors confirm his standing in the field. Dr. Sawai exemplifies dedication to science, education, and compassionate patient care, making him an ideal candidate for prestigious recognition such as the Best Researcher Award. His work continues to inspire the next generation of healthcare professionals and researchers in Japan and beyond.

Publications Top Notes

1. Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function

  • Year: 1997

  • Authors: Tanaka A, Nishida R, Sawai K, Nagae T, Shinkai S, Ishikawa M, Maeda K, Murata M, Seta K, Okuda J, Yoshida T, Sugawara A, Kuwahara T

  • Journal: Nihon Jinzo Gakkai Shi

2. Human parvovirus B19 infection resembling systemic lupus erythematosus

  • Year: 1998

  • Authors: Tanaka A, Sugawara A, Sawai K, Kuwahara T

  • Journal: Intern Med

3. Concealed hypothyroidism in patients with myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCA) positive renal disease

  • Year: 1999

  • Authors: Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T

  • Journal: Clinical Nephrology

4. Intraglomerular metastasis from pancreatic cancer

  • Year: 2001

  • Authors: Yokoi H, Nakata M, Sawai K, Yoshida T, Koshikawa M, Joyama S, Tanaka A, Goto M, Ueda S, Senzaki H, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

5. C4d and C4bp deposition along the glomerular capillary walls in a patient with preeclampsia

  • Year: 2001

  • Authors: Joyama S, Yoshida T, Koshikawa M, Sawai K, Yokoi H, Tanaka A, Gotoh M, Ueda S, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

6. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis

  • Year: 2003

  • Authors: Sawai K, Mori K, Mukoyama M, Sugawara A, Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K

  • Journal: Journal of the American Society of Nephrology

7. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis

  • Year: 2004

  • Authors: Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

8. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy

  • Year: 2005

  • Authors: Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K

  • Journal: FASEB Journal

9. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

  • Year: 2005

  • Authors: Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J

  • Journal: Journal of Clinical Investigation

10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

  • Year: 2005

  • Authors: Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Published on by Shen Awards

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Ana Beatriz Pizarro | Health Equity | Young Scientist Award

Published on by Shen Awards

Dr. Ana Beatriz Pizarro | Health Equity | Young Scientist Award

Researcher at Cochrane, Colombia

Ana Beatriz Pizarro is a passionate and accomplished researcher and educator with a strong focus on evidence synthesis, health equity, and climate change. With experience in various international research projects, she has made significant contributions to systematic reviews and health interventions. Ana has developed expertise in evidence-based practices and global health policy, working with renowned institutions like the Cochrane Collaboration and Evidence Aid. Her career spans multiple countries, including Colombia, the USA, the UK, and Chile, showcasing her diverse research and mentoring abilities. Ana is committed to promoting health equity, fostering global collaboration, and mentoring the next generation of researchers. Her work continues to influence and shape research in public health and global health initiatives.

Professional Profile

Education

Ana Beatriz Pizarro holds a Graduate Diploma in Principles and Practice of Clinical Research from Harvard University’s T.H. Chan School of Public Health, completed in 2023. She also earned a Bachelor of Science in Nursing from Pontificia Universidad Javeriana in Bogotá, Colombia, in 2021. Her academic training at these prestigious institutions has equipped her with a solid foundation in both clinical research and public health, allowing her to lead and contribute to numerous high-impact health and systematic review projects. Ana’s educational background blends health sciences with research methodologies, enhancing her ability to approach complex public health issues with evidence-based solutions.

Professional Experience

Ana Beatriz Pizarro has held various significant roles throughout her career. She is currently the Future of Evidence Synthesis Implementation Officer at The Cochrane Collaboration, where she manages the launch of Evidence Synthesis Units, coordinates thematic group applications, and ensures smooth cross-team collaborations. Ana has also served as an Assistant Professor at Universidad San Sebastián in Chile, where she trained students in systematic review methodology. Her previous roles include research associate positions at Universidad del Rosario in Colombia and Texas Christian University in the USA. Ana has also worked internationally, contributing to projects in India, Spain, and the UK, demonstrating her ability to collaborate globally and lead impactful research projects.

Research Interests

Ana’s primary research interests lie in evidence synthesis, systematic reviews, and global health, with a particular focus on health equity, climate change, and healthcare decision-making. She has a strong commitment to addressing health disparities through evidence-based methodologies. Her work spans multiple domains, including the effects of climate change on children’s health, the impact of structural racism on health outcomes, and the development of evidence synthesis frameworks for humanitarian action. Ana is dedicated to improving healthcare policies through rigorous research and believes in the power of evidence to drive positive change in public health and global health systems.

Research Skills

Ana Beatriz Pizarro possesses a wide range of research skills essential for conducting high-quality evidence synthesis. She is highly proficient in systematic review methodologies, risk of bias assessments, data extraction, and analysis. Ana’s experience in literature searches, project coordination, and stakeholder engagement has honed her leadership and communication skills, allowing her to manage multidisciplinary teams and deliver impactful results. She also excels in mentoring students and junior researchers, providing guidance on rigorous research practices. Her ability to adapt research strategies to diverse contexts and learning styles demonstrates her versatility as a researcher. Ana’s expertise in health equity and decision-making frameworks further enhances her skills in creating actionable insights for global health challenges.

Awards and Honors

Ana Beatriz Pizarro has received multiple accolades for her contributions to evidence synthesis and global health research. Notably, she coordinated the Global Health Equity Mentoring Program, which served over 60 underrepresented individuals and led to 50 successful health equity projects. She has also been recognized for her leadership in the Cochrane Library and for her role in improving publication timelines and strategic development. Her work on evidence gaps in humanitarian action, funded by the Pan American Health Organization, has been highly regarded for its contribution to policy and decision-making. Ana’s dedication to promoting health equity and capacity-building in low-resource settings has earned her recognition as a rising leader in the field of global health.

Conclusion

Ana Beatriz Pizarro is a highly promising candidate for the Young Scientist Award due to her leadership in evidence synthesis, her impactful work in health equity, and her extensive international research collaborations. While her career trajectory is impressive, there is an opportunity to build further on independent research and funding achievements. Her dedication to advancing global health, evidence-based practices, and mentorship stands out, positioning her as a future leader in her field. Therefore, Ana is a strong contender for this award, with the potential for even greater contributions to the research community as she continues to grow in her career.

Publication Top Notes

  • Infodemics and health misinformation: a systematic review of reviews
    Authors: IJB Do Nascimento, AB Pizarro, JM Almeida, N Azzopardi-Muscat, …
    Year: 2022
    Journal: Bulletin of the World Health Organization
    Volume: 100 (9), 544
  • Impact of COVID-19 on clinical trials and clinical research: a systematic review
    Authors: B Sathian, M Asim, I Banerjee, AB Pizarro, B Roy, ER van Teijlingen, …
    Year: 2020
    Journal: Nepal Journal of Epidemiology
    Volume: 10 (3), 878
  • Sugar consumption, sugar sweetened beverages and Attention Deficit Hyperactivity Disorder: A systematic review and meta-analysis
    Authors: A Farsad-Naeimi, F Asjodi, M Omidian, M Askari, M Nouri, AB Pizarro, …
    Year: 2020
    Journal: Complementary Therapies in Medicine
    Volume: 53, 102512
  • Evidence synthesis relevant to COVID-19: a protocol for multiple systematic reviews and overviews of systematic reviews
    Authors: G Rada G, F Verdugo-Paiva, C Ávila, M Morel-Marambio, R Bravo-Jeria, …
    Year: 2020
  • Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study
    Authors: B Quiroga, MJ Soler, A Ortiz, S Martínez Vaquera, CJ Jarava Mantecón, …
    Year: 2022
    Journal: Nephrology Dialysis Transplantation
    Volume: 37 (10), 1868-1878
  • Effect of DASH diet on oxidative stress parameters: A systematic review and meta-analysis of randomized clinical trials
    Authors: R Pirouzeh, N Heidarzadeh-Esfahani, M Morvaridzadeh, A Izadi, …
    Year: 2020
    Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews
    Volume: 14 (6), 2131-2138
  • Effect of soy products and isoflavones on oxidative stress parameters: A systematic review and meta-analysis of randomized controlled trials
    Authors: M Morvaridzadeh, SM Nachvak, S Agah, M Sepidarkish, F Dehghani, …
    Year: 2020
    Journal: Food Research International
    Volume: 137, 109578
  • Vitamin C for the treatment of COVID-19: A living systematic review protocol
    Authors: E Baladia, AB Pizarro, G Rada
    Year: 2020
    Journal: medRxiv
  • Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis
    Authors: S Fazelian, F Moradi, S Agah, A Hoseini, H Heydari, M Morvaridzadeh, …
    Year: 2021
    Journal: BMC Nephrology
    Volume: 22 (1), 160
  • Effect of alpha-lipoic acid on oxidative stress parameters: A systematic review and meta-analysis
    Authors: SR Zonooz, M Hasani, M Morvaridzadeh, AB Pizarro, H Heydari, …
    Year: 2021
    Journal: Journal of Functional Foods
    Volume: 87, 104774

 

Faezeh Zakerinasab | Health Professions | Women Researcher Award

Published on by Shen Awards

Dr. Faezeh Zakerinasab | Health Professions | Women Researcher Award

Dr. Faezeh Zakerinasab, Mashhad university of medical Sci, Iran

Dr. Faezeh Zakerinasab is a researcher and academic affiliated with Mashhad University of Medical Sciences in Iran. With a focus on [specific field or specialty, if known], Dr. Zakerinasab has contributed to various studies and publications that enhance the understanding of [mention specific topics or areas of research]. She is dedicated to advancing medical science and improving healthcare outcomes through her research and teaching efforts.

Profile:

 

Education:

Dr. Faezeh Zakerinasab is a physician and healthcare management professional currently affiliated with Mashhad University of Medical Sciences in Iran. She earned her Doctor of Medicine (MD) from Mashhad University of Medical Sciences, graduating in 2022. Following her medical training, she pursued an MBA in Healthcare Management at Ferdowsi College of Economic & Administrative Science, expected to complete in 2024. Dr. Zakerinasab is committed to integrating medical expertise with effective healthcare administration to improve patient outcomes and healthcare delivery.

Voluntary Experiences:

Dr. Faezeh Zakerinasab has actively contributed to the COVID-19 vaccination project in Mashhad, Iran, serving as a general physician and executive manager. She participated voluntarily beyond her academic program in the obstetrics and gynecology clinic to deepen her understanding of women’s health issues. During her externships and internships, Dr. Zakerinasab conducted free blood sugar screenings, nutritional counseling, and blood pressure testing at Mellat Park in Mashhad, showcasing her commitment to community health and education while studying basic medical sciences.

Certificates:

Dr. Faezeh Zakerinasab is a physician from Mashhad University of Medical Sciences, Iran, with specialized training in various advanced laboratory techniques. She has obtained certifications in cell culture, Western blotting, real-time PCR, and the application of imaging techniques. Additionally, Dr. Zakerinasab is skilled in oocyte and embryo vitrification, bioinformatics, and reproductive biology. Her diverse skill set enhances her ability to contribute to research and practice in reproductive health and related fields.

Publication Top Notes:

Risk of Neonatal Outcomes Associated with COVID-19 Infection during Pregnancy: A Retrospective Cohort Study

Authors: M Mahmoudinia, T Sadeghi, N Sheikhi, M Niknazar, F Zakerinasab

Journal: International Journal of Pediatrics

Year: 2023

Volume: 11

Issue: 7

Pages: 18027-18036

Live Birth after Cleavage-Stage versus Blastocyst-Stage Embryo Transfer in Assisted Reproductive Technology: A Randomised Controlled Study

Authors: M Mahmoudinia, B Sovizi, SMR Ebadi, F Zakerinasab, T Sadeghi, …

Journal: International Journal of Fertility and Sterility

Year: 2024

Volume: 18

Supplement: 1

Pages: 10-16

BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis

Authors: F Zakerinasab, Q Behfar, R Parsaee, RH Zadeh, E Foroughi, A Amirbeik, …

Journal: BMC Genomic Data

Year: 2024

Volume: 25

Issue: 1

Page: 13

Frequency of Skin Diseases in Dermatology Consultations: Descriptive Research

Authors: FZN Seddigheh Hossein-Nejad, Yalda Nahidi, Shatila Torabi, Lida Jarahi, …

Journal: Turkiye Klinikleri Journal of Dermatology

Year: 2023

Volume: 23

Issue: 2

The effect of intravenous Calcium gluconate on the prevention of Ovarian Hyperstimulation Syndrome. (A randomized clinical trial)

Authors: M Lotfalizadeh, N Khadem, M Mahmoudinia, P Faraji, F Zakerinasab, …

Journal: Journal of Gynecology Obstetrics and Human Reproduction

Year: 2024

Article ID: 102850

The effects of growth hormone supplementation in poor ovarian responders undergoing in vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis

Authors: F Zakerinasab, Q Behfar, R Parsaee, FA Mojeni, A Ansari, N Deravi, …

Journal: Turk J Obstet Gynecol

Year: 2024

Volume: 21

Issue: 3

Pages: 208-218

Live birth after cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology: a randomised controlled study

Authors: M Maliheh, B Souizi, SMR Ebadi, F Zakerinasab, T Sadeghi, …

Journal: International Journal of Fertility & Sterility

Year: 2024

Volume: 18

Supplement: 1

Page: 10

Association between Maternal smoking during pregnancy and risk of ADHD: a systematic review and meta-analysis of prospective cohort studies

Authors: F Zakerinasab

Platform: OSF

Year: 2023

The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: A systematic review and meta-analysis of randomized controlled trials

Authors: RK Faezeh Zakerinasab, Qumars Behfar, Reza Parsaee, Fariba Arbab Mojeni, …

Journal: Obstetrics and Gynecology International

Year: 2023

Obstetric Patients with Coronavirus Disease: Symptoms and Critical Illness & Mortality in 2019 (COVID-19) Infection in Imam Reza’s Hospital

Authors: AM Faezeh Zakerinasab, Jamshid Jamali, Tahereh Sadeghi, Nafiseh Jahanpak, …

Journal: Journal of Midwifery & Reproductive Health

Year: 2023

Effect of co-administration of gonadotropins and letrozole during ovarian stimulation on IVF outcome for poor responders: a systematic review and meta-analysis of randomized controlled trials

Authors: F Zakerinasab*, Qumars Behfar, Reza Parsaee, Mahdis Sadat Miri, …

Journal: [Journal Name Not Provided]

Year: [Year Not Provided]